| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.8M | -40.2% |
| R&D Expense | $100.9M | +77.4% |
| SG&A Expense | $35.2M | +36.3% |
| Operating Income | -$134.3M | -68.5% |
| Interest Expense | $500K | — |
| Net Income | -$129.9M | -63.5% |
| EPS (Basic) | -$4.05 | +39.2% |
| EPS (Diluted) | -$4.05 | +39.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $431.2M | +115.4% |
| Total Assets | $435.1M | +113.6% |
| Current Liabilities | $33.3M | +144.6% |
| Long-term Debt | $4.6M | — |
| Total Liabilities | $40.0M | +150.3% |
| Stockholders' Equity | $395.1M | +110.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.8M | -71.9% |
| Capital Expenditures | $797K | +135.8% |
| Investing Cash Flow | -$115.1M | -55.0% |
| Financing Cash Flow | $322.2M | +157.2% |
| Free Cash Flow | -$94.6M | -72.3% |